A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the pathogenic agent leading to COVID-19. Due to high speed of transmission and mutation rates, universal diagnosis and appropriate prevention are still urgently needed. The nucleocapsid protein of SARS-CoV-2 is considered more conserve...

Full description

Bibliographic Details
Main Authors: Zehui Li, Aiping Wang, Jingming Zhou, Yumei Chen, Hongliang Liu, Yankai Liu, Ying Zhang, Peiyang Ding, Xifang Zhu, Chao Liang, Yanhua Qi, Enping Liu, Gaiping Zhang
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/11/6225
_version_ 1797493032297168896
author Zehui Li
Aiping Wang
Jingming Zhou
Yumei Chen
Hongliang Liu
Yankai Liu
Ying Zhang
Peiyang Ding
Xifang Zhu
Chao Liang
Yanhua Qi
Enping Liu
Gaiping Zhang
author_facet Zehui Li
Aiping Wang
Jingming Zhou
Yumei Chen
Hongliang Liu
Yankai Liu
Ying Zhang
Peiyang Ding
Xifang Zhu
Chao Liang
Yanhua Qi
Enping Liu
Gaiping Zhang
author_sort Zehui Li
collection DOAJ
description Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the pathogenic agent leading to COVID-19. Due to high speed of transmission and mutation rates, universal diagnosis and appropriate prevention are still urgently needed. The nucleocapsid protein of SARS-CoV-2 is considered more conserved than spike proteins and is abundant during the virus’ life cycle, making it suitable for diagnostic applications. Here, we designed and developed a fluorescent immunochromatography assay (FICA) for the rapid detection of SARS-CoV-2-specific antibodies using ZnCdSe/ZnS QDs-conjugated nucleocapsid (N) proteins as probes. The nucleocapsid protein was expressed in <i>E.coli</i> and purified via Ni-NTA affinity chromatography with considerable concentration (0.762 mg/mL) and a purity of more than 90%, which could bind to specific antibodies and the complex could be captured by <i>Staphylococcal</i> protein A (SPA) with fluorescence displayed. After the optimization of coupling and detecting conditions, the limit of detection was determined to be 1:1.024 × 10<sup>5</sup> with an IgG concentration of 48.84 ng/mL with good specificity shown to antibodies against other zoonotic coronaviruses and respiratory infection-related viruses (<i>n</i> = 5). The universal fluorescent immunochromatography assay simplified operation processes in one step, which could be used for the point of care detection of SARS-CoV-2-specific antibodies. Moreover, it was also considered as an efficient tool for the serological screening of potential susceptible animals and for monitoring the expansion of virus host ranges.
first_indexed 2024-03-10T01:14:10Z
format Article
id doaj.art-6d14a7543be74a3ba5d23296d48d7d10
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T01:14:10Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-6d14a7543be74a3ba5d23296d48d7d102023-11-23T14:11:51ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-06-012311622510.3390/ijms23116225A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid ProteinZehui Li0Aiping Wang1Jingming Zhou2Yumei Chen3Hongliang Liu4Yankai Liu5Ying Zhang6Peiyang Ding7Xifang Zhu8Chao Liang9Yanhua Qi10Enping Liu11Gaiping Zhang12School of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSchool of Life Science, Zhengzhou University, Zhengzhou 450001, ChinaSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the pathogenic agent leading to COVID-19. Due to high speed of transmission and mutation rates, universal diagnosis and appropriate prevention are still urgently needed. The nucleocapsid protein of SARS-CoV-2 is considered more conserved than spike proteins and is abundant during the virus’ life cycle, making it suitable for diagnostic applications. Here, we designed and developed a fluorescent immunochromatography assay (FICA) for the rapid detection of SARS-CoV-2-specific antibodies using ZnCdSe/ZnS QDs-conjugated nucleocapsid (N) proteins as probes. The nucleocapsid protein was expressed in <i>E.coli</i> and purified via Ni-NTA affinity chromatography with considerable concentration (0.762 mg/mL) and a purity of more than 90%, which could bind to specific antibodies and the complex could be captured by <i>Staphylococcal</i> protein A (SPA) with fluorescence displayed. After the optimization of coupling and detecting conditions, the limit of detection was determined to be 1:1.024 × 10<sup>5</sup> with an IgG concentration of 48.84 ng/mL with good specificity shown to antibodies against other zoonotic coronaviruses and respiratory infection-related viruses (<i>n</i> = 5). The universal fluorescent immunochromatography assay simplified operation processes in one step, which could be used for the point of care detection of SARS-CoV-2-specific antibodies. Moreover, it was also considered as an efficient tool for the serological screening of potential susceptible animals and for monitoring the expansion of virus host ranges.https://www.mdpi.com/1422-0067/23/11/6225SARS-CoV-2fluorescent immunochromatography assaynucleocapsid proteinquantum dotspoint-of-care detection
spellingShingle Zehui Li
Aiping Wang
Jingming Zhou
Yumei Chen
Hongliang Liu
Yankai Liu
Ying Zhang
Peiyang Ding
Xifang Zhu
Chao Liang
Yanhua Qi
Enping Liu
Gaiping Zhang
A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein
International Journal of Molecular Sciences
SARS-CoV-2
fluorescent immunochromatography assay
nucleocapsid protein
quantum dots
point-of-care detection
title A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein
title_full A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein
title_fullStr A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein
title_full_unstemmed A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein
title_short A Universal Fluorescent Immunochromatography Assay Based on Quantum Dot Nanoparticles for the Rapid Detection of Specific Antibodies against SARS-CoV-2 Nucleocapsid Protein
title_sort universal fluorescent immunochromatography assay based on quantum dot nanoparticles for the rapid detection of specific antibodies against sars cov 2 nucleocapsid protein
topic SARS-CoV-2
fluorescent immunochromatography assay
nucleocapsid protein
quantum dots
point-of-care detection
url https://www.mdpi.com/1422-0067/23/11/6225
work_keys_str_mv AT zehuili auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT aipingwang auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT jingmingzhou auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT yumeichen auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT hongliangliu auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT yankailiu auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT yingzhang auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT peiyangding auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT xifangzhu auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT chaoliang auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT yanhuaqi auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT enpingliu auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT gaipingzhang auniversalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT zehuili universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT aipingwang universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT jingmingzhou universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT yumeichen universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT hongliangliu universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT yankailiu universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT yingzhang universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT peiyangding universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT xifangzhu universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT chaoliang universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT yanhuaqi universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT enpingliu universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein
AT gaipingzhang universalfluorescentimmunochromatographyassaybasedonquantumdotnanoparticlesfortherapiddetectionofspecificantibodiesagainstsarscov2nucleocapsidprotein